iECURE
company
About
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $65M
- Industries
- Biotechnology,Genetics
- Founded date
- Jan 1, 2012
- Number Of Employee
- 251 - 500
- Operating Status
- Active
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$115M
iECURE has raised a total of
$115M
in funding over 2 rounds. Their latest funding was raised on
Nov 30, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | Series A | $65M | 1 | — | — | Detail |
| Sep 9, 2021 | Series A | $50M | 1 |
Versant Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
iECURE has made 1 investments. Their most recent investment was on
Nov 29, 2022, when Flourish Fi raised $2.30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Flourish Fi
|
Seed | $2.30M | Financial Services | — |
Investors
Number of Lead Investors
Number of Investors
1
1
iECURE is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
